The vaccine manufacturer Pfizer has submitted an application for the approval of its corona vaccine booster for children, Swissmedic is now examining this.
Essentials in Brief 1- Pfizer also wants to be able to boost children 2- The vaccine manufacturer has submitted an application for approval in Switzerland.
The pharmaceutical company Pfizer has submitted an application to Swissmedic for a booster vaccination against the coronavirus for children aged five and over.
The vaccine has been approved for primary immunization in Switzerland for children aged 5 to 11 since December 2021.
The request for a new dosage recommendation includes a booster vaccination for children aged five to eleven years at least 6 months after the basic immunization with the Covid 19 children’s vaccine, as Swissmedic announced on Tuesday.
The Institute for Therapeutic Products is now assessing the benefits and risks of the new dosage recommendation based on the data submitted .
Vaccine Booster already approved
Pfizer/Biontech’s Comirnaty vaccine for children aged 5 to 11 has been approved in Switzerland since December 10, 2021.
The dosage and administration are different from the Comirnaty vaccine for people over 12 years old.
The vaccine booster used in children has a lower concentration (10 micrograms) and the injection volume (0.25 milliliters) is four times smaller than in adults.
The booster is an additional vaccination dose that is administered to vaccinated people who have completed their basic immunization course in order to refresh their immunological memory.